Artera, Inc.

Artera, Inc. is a digital health SaaS company headquartered in Santa Barbara, California. The company's core business revolves around providing an AI-powered patient communications platform, utilizing virtual agents (voice and text) to enhance the patient experience across the entire healthcare journey. Its mission is to transform patient communication, aiming to make healthcare a leading industry in customer service by fostering efficient and convenient interactions between patients and healthcare providers.

Artera's platform offers a comprehensive suite of services, including self-scheduling, intake, forms, billing, and follow-ups, all powered by artificial intelligence. The company serves a broad market segment, trusted by over 1,000 healthcare organizations, including specialty groups, Federally Qualified Health Centers (FQHCs), large Integrated Delivery Networks (IDNs), and federal agencies, collectively engaging 100 million patients annually. The platform supports over 2 billion communications in 109 languages across various channels like voice, text, and web, and integrates seamlessly with leading Electronic Health Records (EHRs) and digital health vendors.

In recent news, Artera secured $65 million in growth funding in December 2025, led by Lead Edge Capital, to accelerate the adoption of agentic AI in healthcare. The company was recognized as #1 Best in KLAS for Patient Communications in February 2026 and was listed in Deloitte's 2025 Technology Fast 500. Artera also expanded its executive leadership team in March 2026, appointing a new CTO and promoting a People Team Leader. Guillaume de Zwirek serves as the CEO and founder, guiding the company's focus on improving patient access and communication workflows.

Latest updates

Artera AI Agents Boost Colonoscopy Adherence for Atlantic Health

Event summary

  • Atlantic Health deployed Artera's AI Agents for colonoscopy patient outreach, marking their first use of AI for outbound patient communication.
  • Within 30 days, the AI Agent achieved a 43% call answer rate, a 39% appointment confirmation rate, and handled 7% of patient inquiries.
  • The AI Agent reduced gastrointestinal procedure scheduler manual call volume by 38%, freeing up staff for higher-level patient care.
  • Artera, a partner of Atlantic Health for over six years, is positioning itself as a leader in agentic AI for healthcare.

The big picture

The partnership highlights the growing adoption of AI to address persistent challenges in healthcare, particularly in preventative care where patient adherence remains a significant barrier. This deployment represents a shift towards digital-first patient engagement strategies, potentially reducing operational costs and improving health outcomes. The success of Artera’s agentic AI model could accelerate its adoption across the broader healthcare landscape, impacting the competitive dynamics of patient communication platforms.

What we're watching

Scalability
The success of this pilot program hinges on Artera's ability to scale its AI Agent deployment across Atlantic Health's extensive network of facilities and diverse patient population.
Data Privacy
Increased reliance on AI for patient communication will necessitate rigorous adherence to HIPAA and other data privacy regulations, potentially creating operational and legal hurdles.
Integration Risk
The long-term value of Artera's solution depends on seamless integration with Atlantic Health's existing EHR and operational systems, which could be complex and time-consuming.

Artera Bolsters AI Leadership Amidst Healthcare Agentic Push

Event summary

  • Artera appointed Damon Lanphear as CTO, following his tenure at Amazon and 98point6.
  • Nicole Ossey was promoted to SVP of People, previously VP of People & Culture at Knock.
  • Artera secured a $65 million growth investment to expand agentic AI capabilities.
  • The company processes over 2 billion patient communications annually.
  • AI Co-Pilots are deployed by over 100 healthcare providers, and Flows Agents handle over 42 million sessions annually.

The big picture

Artera's investment and leadership changes signal a significant bet on agentic AI to address persistent inefficiencies in healthcare communications. The company's focus on automating patient interactions aligns with the broader trend of leveraging AI to reduce administrative burden and improve patient access, but also introduces new risks related to data security and regulatory compliance. The success of this strategy hinges on Artera’s ability to effectively integrate new technologies and talent while navigating a complex regulatory landscape.

What we're watching

Technical Integration
Lanphear's experience integrating AI into large organizations like Amazon will be critical; the challenge lies in translating that scale to Artera's existing infrastructure and workflows.
Talent Retention
With rapid scaling and a shift to AI-driven workflows, Artera must ensure Ossey's people initiatives retain key talent and cultivate a culture adaptable to evolving roles.
Regulatory Scrutiny
As agentic AI becomes more prevalent in healthcare, increased regulatory scrutiny around data privacy, security, and algorithmic bias could impact Artera's growth trajectory.

Artera's Agentic AI Push Signals Shift in Healthcare Patient Access

Event summary

  • Artera will showcase its AI-powered patient communication solutions at HIMSS 2026, booth #6421.
  • The company has reached $100M CARR and was recognized as the 2026 Best in KLAS winner for Patient Communications.
  • Artera is hosting sessions focused on Agentic AI, including a fireside chat with Signify Research analyzing Voice AI adoption in specialty practices.
  • The company has deployed its AI Agents, Flows Agents, and Co-Pilots to over 1,000 healthcare organizations, saving millions of staff hours.

The big picture

Artera's focus on agentic AI reflects a broader trend in healthcare towards automating administrative tasks and improving patient access. The company's Best in KLAS award and $100M CARR demonstrate the growing market demand for AI-powered communication solutions, but also highlight the pressure to deliver measurable ROI and address security concerns as AI becomes more integrated into clinical workflows. The partnership with Signify Research underscores the strategic importance of data-driven insights in guiding AI adoption within the healthcare sector.

What we're watching

ROI Credibility
The framework introduced by Signify Research for assessing AI investments will be crucial for Artera to demonstrate tangible financial returns to potential clients, particularly in specialty practices.
MCP Adoption
The success of Artera's Model Context Protocol (MCP) in achieving healthcare interoperability and mitigating AI risks will determine its broader adoption and influence the evolution of patient-facing automation.
Competitive Landscape
The rapid innovation in agentic AI will likely intensify competition, requiring Artera to continually differentiate its offerings and maintain its 'Best in KLAS' standing.

Artera's KLAS #1 Ranking Signals Agentic AI Dominance in Healthcare Communications

Event summary

  • Artera has been named #1 Best in KLAS for Patient Communications in 2026, based on feedback from over 20 healthcare providers.
  • The company achieved an overall performance score of 89.8 with A- grades across all six KLAS evaluation categories.
  • Artera recently secured a $65 million growth investment and surpassed $100 million in Contracted Annual Recurring Revenue (CARR).
  • Hundreds of healthcare providers have deployed Artera's AI Co-Pilots and Flows Agents, resulting in millions of staff hours saved and 42 million unique sessions annually.
  • Artera's Flows Agents achieve 94% conversation completion without staff intervention.

The big picture

Artera's recognition as the top patient communications vendor underscores the growing importance of AI-powered automation in healthcare administration. The company's success reflects a broader trend of providers seeking to alleviate staff burnout and improve patient engagement through digital solutions. With a $100 million ARR and significant investment, Artera is well-positioned to capitalize on this trend, but faces the challenge of maintaining its lead in a rapidly evolving market.

What we're watching

Adoption Rate
The continued adoption of Artera's AI Co-Pilots and Flows Agents will be crucial to demonstrating long-term value and justifying the recent growth investment.
Competitive Landscape
Increased competition in the agentic AI space could pressure Artera's pricing and margins, requiring ongoing innovation and differentiation.
Regulatory Risk
Evolving regulations surrounding AI in healthcare, particularly concerning data privacy and security, may necessitate adjustments to Artera's product offerings and operational practices.

Rural Health System Boosts Rx Adherence with AI-Powered Messaging

Event summary

  • Beauregard Health System integrated Artera's AI communication platform with DrFirst's prescription engagement solution within its MEDITECH Expanse EHR.
  • The integration delivers personalized text messages to patients aged 18+ with new prescriptions, using the provider's 10-digit number.
  • Post-implementation data (June-December 2025) shows a 500% increase in prescription-related messages, 550% in educational content views, and 650% in pick-up reminders.
  • Beauregard Health System serves a large population of Medicare and Medicaid patients in a rural Louisiana community with limited broadband access.

The big picture

This integration highlights the growing trend of leveraging AI and digital communication to improve patient engagement and medication adherence, particularly in underserved rural communities. The reliance on text messaging underscores the challenges of limited broadband access and the need for accessible communication channels. The partnership between Artera and DrFirst demonstrates a shift towards interoperable solutions within the healthcare IT ecosystem, moving beyond siloed EHR systems.

What we're watching

Scalability
The success of this model hinges on Artera and DrFirst's ability to scale the integration across other MEDITECH clients, demonstrating broader applicability beyond Beauregard.
Cost Impact
Whether the increased patient engagement and adherence translate into tangible cost savings for Beauregard Health System and payers remains to be seen, and will be a key driver of adoption.
Regulatory Risk
Increased reliance on text messaging for healthcare communication may draw greater regulatory scrutiny regarding data privacy and security, potentially impacting future implementation strategies.

Artera's Agentic AI Push Bolstered by $65M Investment, Executive Shakeup

Event summary

  • Artera ranked 162nd on the Deloitte Technology Fast 500, demonstrating 502% revenue growth from 2021 to 2024.
  • The company has secured a $65 million growth investment to accelerate the adoption of agentic AI for patient communications.
  • Artera has surpassed $100 million in CARR (Contract Annual Recurring Revenue).
  • Four key executive appointments were announced: Tom McIntyre (President), Michael Jensen (CFO), Zach Wood (Chief Product & Strategy Officer), and Emily Coy (VP, Communications & Integrated Marketing).

The big picture

Artera's recognition on the Deloitte Technology Fast 500, coupled with the significant growth investment and executive appointments, signals a strategic bet on agentic AI within the healthcare sector. The company is positioned to capitalize on the growing demand for automation and efficiency gains in patient communications, but faces increasing competition and potential regulatory hurdles as the market matures. The $100M CARR milestone demonstrates a clear market validation of their approach, but scaling agentic AI solutions across diverse healthcare organizations presents operational challenges.

What we're watching

Execution Risk
The integration of the new executive team and the deployment of the $65 million investment will be critical to Artera’s continued growth trajectory.
Competitive Landscape
The rapid expansion of agentic AI in healthcare will likely intensify competition, requiring Artera to differentiate its offerings and maintain technological leadership.
Regulatory Scrutiny
Increased adoption of AI in healthcare will draw greater regulatory attention, potentially impacting Artera's compliance costs and operational flexibility.
CID: 1671